Reposal

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Addbot (talk | contribs) at 17:05, 16 March 2013 (Bot: Migrating 1 interwiki links, now provided by Wikidata on d:q138339). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Reposal
Clinical data
Other namesReposal, 5-Ethyl-5-(bicyclo(3.2.1)octenyl)barbituric acid
ATC code
Identifiers
  • 5-bicyclo[3.2.1]oct-2-en-3-yl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione
CAS Number
PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H18N2O3
Molar mass262.304 g/mol g·mol−1
3D model (JSmol)
  • O=C1NC(=O)NC(=O)C1(CC)C=3C[C@H]2C[C@H](CC2)C=3
  • InChI=1S/C14H18N2O3/c1-2-14(11(17)15-13(19)16-12(14)18)10-6-8-3-4-9(5-8)7-10/h6,8-9H,2-5,7H2,1H3,(H2,15,16,17,18,19)/t8-,9+/m0/s1 checkY
  • Key:MKELYWOVSPVORM-DTWKUNHWSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Reposal is a barbiturate derivative invented in the 1960s in Denmark. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia.[1][2][3]

References

  1. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 14103836, please use {{cite journal}} with |pmid=14103836 instead.
  2. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 14103837, please use {{cite journal}} with |pmid=14103837 instead.
  3. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 5756387, please use {{cite journal}} with |pmid=5756387 instead.